Clinical Trials for AB Science

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: AB Science

Clinical Trials (6)

Masitinib in Patients With Mild Alzheimer's Disease

PHASE3Not yet recruiting

600 participants

Started: Jun 30, 2026 · Completed: Dec 31, 2029

1 condition1 sponsor9 locations

Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients

PHASE3Not yet recruiting

412 participants

Started: Jan 1, 2026 · Completed: Dec 31, 2029

1 condition1 sponsor1 location

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

7,000 participants

Started: Mar 1, 2024 · Completed: Apr 30, 2027

5 conditions13 sponsors3 locations

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

PHASE3Active, not recruiting

800 participants

Started: Jun 28, 2022 · Completed: Dec 31, 2028

1 condition1 sponsor37 locations

AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

PHASE1/PHASE2Recruiting

78 participants

Started: Jun 1, 2022 · Completed: Dec 31, 2026

3 conditions1 sponsor10 locations

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

PHASE3Recruiting

495 participants

Started: Feb 2, 2021 · Completed: Dec 31, 2027

1 condition1 sponsor56 locations